Delivering powdered, needle-free vaccines.
Delivering DNA and RNA Vaccines Where and How They Are Needed.
INTRODUCING ORLANCE MACH-1 ™
LOW-DOSE, NEEDLE-FREE POWDERED NUCLEIC ACID VACCINES WITHOUT COLD CHAIN REQUIREMENTS.
Orlance aims to deliver powdered, needle-free, shelf-stable, nucleic acid vaccines (DNA and/or RNA) with its epidermal vaccine delivery platform.
Meet Us At:
JPMorgan Week, San Francisco
- FreeMind Group Non-Dilutive Funding Summit
15 January, 2025. - Fierce JPM Week, virtual
22-24 January, 2025.
Drug Delivery Summit 2025, San Diego (speaker)
3 to 4 February, 2025.
MD&M West, Anaheim (speaker)
5 to 6 February, 2025.
World Vaccine Congress, Washington, D.C. (speaker)
22 to 24 April, 2025.
Careers
Thank you for your interest in joining the Orlance team. While we currently do not have any openings, please check again another time.
Contact
